Non-specialised wholesale trade
NEPTUNE PHARMA AS
Revenue 2024
NOK 1.1m
Operating profit
NOK −286,000
Equity
NOK −1.5m
Incorporated
2018
Share capital
NOK 30,000
Key figures · 2024
Current ratio
0.50
Equity ratio
-99.1%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -26.3% | |
| Net margin (%%) | -26.5% | |
| Return on assets (%%) | -18.5% | |
| Likviditet | ||
| Current ratio | 0.50 | |
| Working capital | −1.1m | |
| Soliditet | ||
| Equity ratio (%%) | -99.1% | |
| Debt-to-equity ratio | -2.01 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.